STAT+: Health tech’s newest unicorn is running toward Medicaid patients long marginalized in medicine

It has become a business imperative in American medicine to marginalize patients on Medicaid. Their health problems can be costly and complicated — often, the product of other structural barriers that stand in the way of good health — and lower government reimbursement means doctors typically lose money on their care.

But a Brooklyn, N.Y.-based startup called Cityblock Health is turning that equation on its head by running toward the very patients many providers run away from. This month, its model of delivering stepped-up primary care to low-income patients raked in $160 million from venture capital firms. That funding — which values the 3-year-old company at $1 billion — signals a significant bet from investors who believe Cityblock can succeed in an area where payers have failed for years.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis.
Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What’s included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.